Platelet haemostatic function in psychiatric disorders:Effects of antidepressants and antipsychotic drugs
The DOI matches its Crossref record; 129 of the 130 references it cites were found in a registry or an index.
Abstract
Objectives Platelets, the smallest anucleated blood cells, play an essential role in the first step of complex haemostatic process. This review presents the haemostatic function of blood platelets related to their activation in psychiatric disorders (schizophrenia, depression), the role of antipsychotic and antidepressant medication, and introduces the mechanisms by which activated platelets may be involved in the pathophysiology of these disorders. Methods Platelets are interesting and easily accessible blood cells to study biochemical pathways related to schizophrenia and other psychiatric disorders, and their complex activation process might be useful as a diagnostic peripheral marker for studying psychiatric disorders and haemostatic complications. Results The excessive activation of platelets observed in patients with depression and schizophrenia is involved in cardiovascular diseases, stroke and increased risk of thrombotic complications that may be major causes of morbidity and mortality of patients. The use of antidepressants or antipsychotic drugs in depression and schizophrenia treatment is often associated with haematological side effects such as bleeding, venous thromboembolism and impaired platelet function. Conclusions Understanding the role of platelet activation in psychiatric disorders such as schizophrenia or depression and medication may improve therapies in the future.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similarly, PLR can also be used as a predictor of the inflammatory response.”
In the citing paper
“Platelet activation is mediated by serotonin, dopamine, glutamate, cytokines and P-selectin, all of them plays an important role in psychiatric disorders (Dietrich-Muszalska and Wachowicz, 2017).”
From Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: effect of inflammatory biomarkers at three-month follow-up (2021) · cites this paper as Dietrich-Muszalska and Wachowicz, 2017
Citations
Cites
1 retracted
Retracted:De novo protein synthesis in mature platelets: a consideration for transfusion medicine
Schubert, P., & Devine, D. V. (2010) · Vox Sanguinis · doi:10.1111/j.1423-0410.2010.01333.x · Cited by 75
RetractedTwo new Later Stone Age sites from the Final Pleistocene in the Falémé Valley, eastern Senegal
Ndiaye, M., Lespez, L., Tribolo, C., Rassé, M., Hadjas, I., Davidoux, S., Huysecom, É., & Douze, K. (2024) · Monash University Research Portal (Monash University) · doi:10.3929/ethz-b-000667478 · Cited by 23,868
Calamita, E., Schmid, M., Kunz, M., Ndebele-Murisa, M. R., Magadza, C. H. D., Nyambe, I., & Wehrli, B. (2019) · Figshare · doi:10.26181/6153922fe919c · Cited by 4,222
Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta‐analysis
CHU, S. G., BECKER, R. C., BERGER, P. B., BHATT, D. L., EIKELBOOM, J. W., KONKLE, B., MOHLER, E. R., REILLY, M. P., & BERGER, J. S. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03584.x · Cited by 1,043
Ischiropoulos, H. (1998) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1998.0755 · Cited by 1,022
Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter
Owens, M. J., & Nemeroff, C. B. (1994) · Clinical Chemistry · doi:10.1093/clinchem/40.2.288 · Cited by 929
Signaling During Platelet Adhesion and Activation
Li, Z., Delaney, M. K., O'Brien, K. A., & Du, X. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.207522 · Cited by 911
Symptoms of depression, acute myocardial infarction, and total mortality in a community sample
Barefoot, J. C., & Schroll, M. (1996) · Circulation · doi:10.1161/01.cir.93.11.1976 · Cited by 850
Depression as a risk factor for cardiac mortality and morbidity
Carney, R. M., Freedland, K. E., Miller, G. E., & Jaffe, A. S. (2002) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(02)00311-2 · Cited by 746
Exaggerated platelet reactivity in major depression
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.10.1313 · Cited by 566
Platelet activation: assessment and quantification
Kamath, S. (2001) · European Heart Journal · doi:10.1053/euhj.2000.2515 · Cited by 516
Platelets at work in primary hemostasis
Broos, K., Feys, H. B., De Meyer, S. F., Vanhoorelbeke, K., & Deckmyn, H. (2011) · Blood Reviews · doi:10.1016/j.blre.2011.03.002 · Cited by 502
George, J. N. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02175-9 · Cited by 457
Free radicals, antioxidant defense systems, and schizophrenia
Wu, J. Q., Kosten, T. R., & Zhang, X. Y. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.02.015 · Cited by 424
Schizophrenia, neuroleptic medication and mortality
Joukamaa, M., Heliövaara, M., Knekt, P., Aromaa, A., Raitasalo, R., & Lehtinen, V. (2006) · British Journal of Psychiatry · doi:10.1192/bjp.188.2.122 · Cited by 395 · cited 4×
“have higher rates of somatic morbidity and mortality when compared to the general population (Allebeck 1989; Joukamaa et al. 2006).”
BackgroundInfluentialStahl, S. M. (1977) · Archives of General Psychiatry · doi:10.1001/archpsyc.1977.01770170019001 · Cited by 388
Schizophrenia: A Life-shortening Disease
Allebeck, P. (1989) · Schizophrenia Bulletin · doi:10.1093/schbul/15.1.81 · Cited by 335
Beyond Clotting: The Powers of Platelets
Leslie, M. (2010) · Science · doi:10.1126/science.328.5978.562 · Cited by 332
Depression and Cardiac Disease: A Review
Celano, C. M., & Huffman, J. C. (2011) · Cardiology in Review · doi:10.1097/crd.0b013e31820e8106 · Cited by 320
Protein synthesis by platelets: historical and new perspectives
WEYRICH, A. S., SCHWERTZ, H., KRAISS, L. W., & ZIMMERMAN, G. A. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.03211.x · Cited by 306
Andrade, C., Sandarsh, S., Chethan, K. B., & Nagesh, K. S. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09r05786blu · Cited by 302
The evolving role of platelets in inflammation
Weyrich, A. S., Lindemann, S., & Zimmerman, G. A. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00304.x · Cited by 294
Zornberg, G. L., & Jick, H. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02784-7 · Cited by 269
Meijer, W. E. E., Heerdink, E. R., Nolen, W. A., Herings, R. M. C., Leufkens, H. G. M., & Egberts, A. C. G. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.21.2367 · Cited by 261
Carney, R. M., Freedland, K. E., Rich, M. W., & Jaffe, A. S. (1995) · Annals of Behavioral Medicine · doi:10.1007/bf02895063 · Cited by 260
Oxidative Stress in Schizophrenia
Grabnar, I., Vovk, T., Kores Plesnicar, B., & Boskovic, M. (2011) · Current Neuropharmacology · doi:10.2174/157015911795596595 · Cited by 250
Sauer, W. H., Berlin, J. A., & Kimmel, S. E. (2003) · Circulation · doi:10.1161/01.cir.0000079172.43229.cd · Cited by 247
Influence of antidepressants on hemostasis
Halperin, D., & Reber, G. (2007) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2007.9.1/dhalperin · Cited by 242
Blockmans, D., Deckmyn, H., & Vermylen, J. (1995) · Blood Reviews · doi:10.1016/0268-960x(95)90020-9 · Cited by 241
Platelets synthesize large amounts of active plasminogen activator inhibitor 1
Brogren, H., Karlsson, L., Andersson, M., Wang, L., Erlinge, D., & Jern, S. (2004) · Blood · doi:10.1182/blood-2004-04-1439 · Cited by 209
Are platelets the link between depression and ischemic heart disease?
Nemeroff, C. B., & Musselman, D. L. (2000) · American Heart Journal · doi:10.1067/mhj.2000.109978 · Cited by 204
Generation of reactive oxygen species in blood platelets
Wachowicz, B., Olas, B., Zbikowska, H. M., & Buczyński, A. (2002) · Platelets · doi:10.1080/09533710022149395 · Cited by 204
Self-citationFunctions of 5-HT2A receptor and its antagonists in the cardiovascular system
Nagatomo, T., Rashid, M., Abul Muntasir, H., & Komiyama, T. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.08.005 · Cited by 185
Skop, B. P., & Brown, T. M. (1996) · Psychosomatics · doi:10.1016/s0033-3182(96)71592-x · Cited by 182
Association of venous thromboembolism and clozapine
Hägg, S., Spigset, O., & Söderström, T. G. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02066-3 · Cited by 173
Platelets and Psychiatry: Lessons Learned From Old and New Studies
Camacho, A., & Dimsdale, J. E. (2000) · Psychosomatic Medicine · doi:10.1097/00006842-200005000-00006 · Cited by 170
Stahl's essential psychopharmacology : the prescriber's guide
Stahl, S. M., Grady, M. M., & Muntner, N. (2014) · Cited by 165
Increased platelet phospholipase A2 activity in schizophrenia
Gattaz, W. (1995) · Schizophrenia Research · doi:10.1016/0920-9964(94)00060-l · Cited by 163
Myers, D. D., Hawley, A. E., Longo, C., Henke, P. K., Guire, K. E., Schmaier, A. H., Wakefield, T. W., & Rectenwald, J. E. (2005) · Thrombosis and Haemostasis · doi:10.1160/th05-06-0426 · Cited by 145
Ay, C., Jungbauer, L., Sailer, T., Tengler, T., Koder, S., Kaider, A., Panzer, S., Quehenberger, P., Pabinger, I., & Mannhalter, C. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2006.085068 · Cited by 131
Antipsychotic-Induced Venous Thromboembolism: A Review of the Evidence
Hägg, S., & Spigset, O. (2002) · CNS Drugs · doi:10.2165/00023210-200216110-00005 · Cited by 126
Redox Control of Platelet Function
Essex, D. W. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2008.2322 · Cited by 113
Schizophrenia as a membrane lipid disorder which is expressed throughout the body
Horrobin, D. F. (1996) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/s0952-3278(96)90138-6 · Cited by 112
Selective serotonin reuptake inhibitors: measurement of effect on platelet function
McCloskey, D. J., Postolache, T. T., Vittone, B. J., Nghiem, K., Monsale, J. L., WESLEY, R. A., & Rick, M. E. (2007) · Translational research · doi:10.1016/j.trsl.2007.10.004 · Cited by 111
Glutamate mediates platelet activation through the AMPA receptor
Morrell, C. N., Sun, H., Ikeda, M., Béïque, J.-C., Swaim, A. M., Mason, E., Martin, T. V., McKnight, L. E., Gözen, O., Ampagoomian, D., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071474 · Cited by 109
Depression, Alterations in Platelet Function, and Ischemic Heart Disease
Bruce, E. C., & Musselman, D. L. (2005) · Psychosomatic Medicine · doi:10.1097/01.psy.0000164227.63647.d9 · Cited by 108
Role of platelets in neuroinflammation: a wide-angle perspective
Horstman, L. L., Jy, W., Ahn, Y. S., Zivadinov, R., Maghzi, A. H., Etemadifar, M., Steven Alexander, J., & Minagar, A. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-10 · Cited by 102
Bismuth-Evenzal, Y., Gonopolski, Y., Gurwitz, D., Iancu, I., Weizman, A., & Rehavi, M. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.08.013 · Cited by 101
Von Känel, R. (2004) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2004.00308.x · Cited by 95
Membrane phospholipid composition, alterations in neurotransmitter systems and schizophrenia
du Bois, T. M., Deng, C., & Huang, X. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.04.034 · Cited by 93
Comorbidity between depression and cardiovascular disease.
Halaris, A. E. (2009) · PubMed · Cited by 91
Zafar, M. U., Paz-Yepes, M., Shimbo, D., Vilahur, G., Burg, M. M., Chaplin, W., Fuster, V., Davidson, K. W., & Badimon, J. J. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehp602 · Cited by 90
Oxidative stress and therapeutic implications in psychiatric disorders
Zhang, X. Y., & Yao, J. K. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.03.003 · Cited by 89
Risk of venous thromboembolism due to antipsychotic drug therapy
Hägg, S., Jönsson, A. K., & Spigset, O. (2009) · Expert Opinion on Drug Safety · doi:10.1517/14740330903117271 · Cited by 86
Glutamate transporters in platelets: EAAT1 decrease in aging and in Alzheimer’s disease
Zoia, C., Cogliati, T., Tagliabue, E., Cavaletti, G., Sala, G., Galimberti, G., Rivolta, I., Rossi, V., Frattola, L., & Ferrarese, C. (2004) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00085-x · Cited by 84
Oxidative stress in blood platelets from schizophrenic patients
Dietrich-Muszalska, A., Olas, B., & Rabe-Jablonska, J. (2005) · Platelets · doi:10.1080/09537100500128872 · Cited by 84
Self-citationIN VITRO EFFECTS OF ANTIPSYCHOTICS ON HUMAN PLATELET ADHESION AND AGGREGATION AND PLASMA COAGULATION
Axelsson, S., Hägg, S., Eriksson, A. C., Lindahl, T. L., & Whiss, P. A. (2007) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2007.04650.x · Cited by 83
D-Dimer as a Risk Factor for Deep Vein Thrombosis: The Leiden Thrombophilia Study
Andreescu, A. C. M., Rosendaal, F. R., & Cushman, M. (2002) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1612942 · Cited by 80
Interferon-gamma increases neuronal death in response to amyloid-beta1-42.
Bate, C., Kempster, S. L., Last, V., & Williams, A. (2006) · Journal of Neuroinflammation · doi:10.1186/1742-2094-3-7 · Cited by 80
The Human Platelet as a Model for the Glutamatergic Neuron: Platelet Uptake of L‐Glutamate
Mangano, R. M., & Schwarcz, R. (1981) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1981.tb01701.x · Cited by 80
Jahn, B., & Hänsch, G. M. (2009) · International Archives of Allergy and Applied Immunology · doi:10.1159/000235282 · Cited by 80
Platelets as Central Mediators of Systemic Inflammatory Responses
Smith, T., & Weyrich, A. S. (2010) · Thrombosis Research · doi:10.1016/j.thromres.2010.10.013 · Cited by 79
Role of reactive nitrogen species in blood platelet functions
Olas, B., & Wachowicz, B. (2007) · Platelets · doi:10.1080/09537100701504087 · Cited by 77
Self-citationHyperhomocysteinemia and Venous Thromboembolism
Cattaneo, M. (2006) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2006-951456 · Cited by 76
The Specificity of Platelet Glutamate Receptor Supersensitivity in Psychotic Disorders
Berk, M., Plein, H., & Belsham, B. (2000) · Life Sciences · doi:10.1016/s0024-3205(00)80002-8 · Cited by 75
Platelet function in patients with major depression
Ziegelstein, R. C., Parakh, K., Sakhuja, A., & Bhat, U. (2009) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2008.01794.x · Cited by 73
Serebruany, V. L., O’Connor, C. M., & Gurbel, P. A. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01562-4 · Cited by 72
Associations Between Venous Thromboembolism and Antipsychotics
Hägg, S., Bate, A., Ståhl, M., & Spigset, O. (2008) · Drug Safety · doi:10.2165/00002018-200831080-00005 · Cited by 72
The platelet as a peripheral marker in psychiatric illness
Plein, H., & Berk, M. (2001) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.251 · Cited by 71
Increased platelet aggregation responses to 5‐hydroxytryptamine in patients taking chlorpromazine.
Boullin, D. J., Woods, H., GRIMES, R. P. J., & Grahame‐Smith, D. (1975) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1975.tb00468.x · Cited by 66
Tseng, Y., Chiang, M.-L., Huang, T., Su, K., Lane, H., & Lai, Y.-C. (2010) · Thrombosis Research · doi:10.1016/j.thromres.2010.09.017 · Cited by 66
Mean Platelet Volume in Patients With Major Depression: Effect of Escitalopram Treatment
Ataoglu, A., & Canan, F. (2009) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181abdfd7 · Cited by 66
Antipsychotics and Venous Thromboembolism Risk: A Meta-Analysis
Zhang, R., Dong, L., Shao, F., Tan, X., & Ying, K. (2011) · Pharmacopsychiatry · doi:10.1055/s-0031-1280814 · Cited by 65
The Role of Serotonin in the Pathophysiology of Depression: As Important As Ever
Nemeroff, C. B., & Owens, M. J. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2009.123752 · Cited by 64
Platelet Glutamate Receptor Supersensitivity in Major Depressive Disorder
Berk, M., Plein, H., & Ferreira, D. (2001) · Clinical Neuropharmacology · doi:10.1097/00002826-200105000-00002 · Cited by 64
The role of serotonin in thrombogenesis.
Clerck, F. D. (1990) · PubMed · Cited by 61
Przyklenk, K., Frelinger, A. L., Linden, M. D., Whittaker, P., LI, Y., Barnard, M. R., Adams, J. W., Morgan, M. E., AL‐SHAMMA, H. A., & Michelson, A. D. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03693.x · Cited by 61
Wallaschofski, H., Eigenthaler, M., Kiefer, M., Donné, M., Hentschel, B., Gertz, H. J., & Lohmann, T. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000088914.24613.51 · Cited by 59
Reduced cyclic AMP production in the blood platelets from schizophrenic patients
Kafka, M. S., van Kammen, D. P., & Bunney, W. E. (1979) · American Journal of Psychiatry · doi:10.1176/ajp.136.5.685 · Cited by 59
Platelets and neurovascular inflammation
Chavakis, T., & Langer, H. F. (2013) · Thrombosis and Haemostasis · doi:10.1160/th13-02-0096 · Cited by 57
Risk of venous thromboembolism during treatment with antipsychotic agents
Masopust, J., Malý, R., & Vališ, M. (2012) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12001 · Cited by 56
Platelet regulation by NO/cGMP signaling and NAD(P)H oxidase-generated ROS
Begonja, A. J., Teichmann, L. L., Geiger, J., Gambaryan, S. P., & Walter, U. (2006) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2005.12.028 · Cited by 56
Das, I., & Khan, N. S. (1998) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/s0952-3278(98)90109-0 · Cited by 56
Platelets in psychiatric disorders
Ehrlich, D., & Humpel, C. (2012) · World Journal of Psychiatry · doi:10.5498/wjp.v2.i6.91 · Cited by 55
Treatment of psychosis: 30 years of progress: Treatment of psychosis: 30 years of progress
De Oliveira, I. R., & Juruena, M. F. (2006) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2006.00784.x · Cited by 55
Antipsychotic drugs and venous thromboembolism
Knudson, J. F., Kortepeter, C. M., DUBITSKY, G. M., Ahmad, S. R., & Chen, M. (2000) · The Lancet · doi:10.1016/s0140-6736(05)74504-9 · Cited by 54
Influence of mental stress on platelet bioactivity
Koudouovoh-Tripp, P., & Sperner‐Unterweger, B. (2012) · World Journal of Psychiatry · doi:10.5498/wjp.v2.i6.134 · Cited by 54
Konopka, L. M., Cooper, R., & Crayton, J. W. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00189-1 · Cited by 54
Blood coagulation and platelet aggregation in major depression
Maes, M. H. J., van der Planken, M., Gastel, A. V., & Desnyder, R. (1996) · Journal of Affective Disorders · doi:10.1016/0165-0327(96)00044-4 · Cited by 52
Pulmonary Thromboembolism Associated with Olanzapine and Risperidone
Borras, L., Eytan, A., de Timary, P., Constant, E.-L., Huguelet, P., & Hermans, C. R. J. R. (2008) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2007.07.074 · Cited by 50
Effects of Serotonin Reuptake Inhibitors on Hemostasis
Alderman, C. P., Seshadri, P., & Ben-Tovim, D. I. (1996) · Annals of Pharmacotherapy · doi:10.1177/106002809603001103 · Cited by 50
Mean platelet volume not so far from being a routine diagnostic and prognostic measurement
Yetkın, E. (2008) · Thrombosis and Haemostasis · doi:10.1160/th08-05-0336 · Cited by 45
Platelet Function in Patients with Depression
Parakh, K., Sakhuja, A., Bhat, U., & Ziegelstein, R. C. (2008) · Southern Medical Journal · doi:10.1097/smj.0b013e318172f732 · Cited by 41
Elevated expression of integrin αIIb βIIIa in drug-naïve, first-episode schizophrenic patients
Walsh, M.-T. H., Ryan, M. C. M., Hillmann, A. G., Condren, R. M., Kenny, D. J., Dinan, T. G., & Thakore, J. H. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01400-2 · Cited by 41
The first- and second-generation antipsychotic drugs affect ADP-induced platelet aggregation
Dietrich‐Muszalska, A., Rabe‐Jabłońska, J., Nowak, P., & Kontek, B. (2010) · The World Journal of Biological Psychiatry · doi:10.3109/15622970802505792 · Cited by 40
Self-citationThrombotic complications of treatment with antipsychotic drugs.
Shulman, M., Njoku, I. J., & Manu, P. (2013) · PubMed · Cited by 39
The changes of aggregability of blood platelets in schizophrenia
Dietrich‐Muszalska, A., & Olas, B. (2008) · The World Journal of Biological Psychiatry · doi:10.1080/15622970701557993 · Cited by 39
Self-citationModifications of blood platelet proteins of patients with schizophrenia
Dietrich‐Muszalska, A., & Olas, B. (2009) · Platelets · doi:10.1080/09537100802641499 · Cited by 39
Self-citationAntipsychotics and risk of venous thromboembolism: A population-based case-control study
Jönsson, A. K., Horváth-Puhó, E., Hägg, S., Pedersen, L. H., & Sørensen, H. T. (2009) · Clinical Epidemiology · doi:10.2147/clep.s4969 · Cited by 39
Depression, antidepressants, and peripheral blood components.
Fišar, Z., & Raboch, J. (2008) · PubMed · Cited by 38
Quetiapine, Olanzapine and Haloperidol Affect Human Plasma Lipid Peroxidation in vitro
Dietrich‐Muszalska, A., Kontek, B., & Rabe‐Jabłońska, J. (2011) · Neuropsychobiology · doi:10.1159/000321623 · Cited by 38
Self-citationOrr, M., & Boullin, D. J. (1976) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1976.tb00648.x · Cited by 35
Mean platelet volume and D-dimer in patients with suspected deep venous thrombosis
Canan, A., Halıcıoğlu, S., & Gürel, S. (2012) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-012-0746-2 · Cited by 34
Clerck, F. D., Somers, Y., Mannaert, E., Greenspan, A. J., & Eerdekens, M. (2004) · Clinical Therapeutics · doi:10.1016/s0149-2918(04)80097-3 · Cited by 34
Depression, anxiety, and platelet reactivity in patients with coronary heart disease
Wittstein, I. S. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq097 · Cited by 33
Hoirisch-Clapauch, S., & Nardi, A. E. (2012) · Medical Hypotheses · doi:10.1016/j.mehy.2012.11.011 · Cited by 30
Platelet aggregation and dense granule secretion in schizophrenia
Yao, J. K., van Kammen, D. P., Gurklis, J. A., & Peters, J. L. (1994) · Psychiatry Research · doi:10.1016/0165-1781(94)90061-2 · Cited by 29
Flöck, A., Zobel, A. W., Bauriedel, G., Tuleta, I., Hammerstingl, C., Höfels, S., Schuhmacher, A., Maier, W., Nickenig, G., & Skowasch, D. (2010) · Thrombosis Research · doi:10.1016/j.thromres.2010.04.020 · Cited by 27
Apoptotic markers in human blood platelets treated with peroxynitrite
Wachowicz, B., Rywaniak, J., & Nowak, P. (2008) · Platelets · doi:10.1080/09537100802406646 · Cited by 26
Self-citationSemız, M., Yücel, H., Kavakçı, Ö., Yıldırım, O., Zorlu, A., Yılmaz, M. B., Küçükdurmaz, Z., & Canan, F. (2013) · PubMed Central · Cited by 24
Dietrich‐Muszalska, A., Kopka, J., & Kwiatkowska, A. (2013) · Neurochemical Research · doi:10.1007/s11064-013-1050-z · Cited by 23
Self-citationSchedel, A., Schloss, P. D., Klüter, H., & Bugert, P. (2008) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-008-0320-9 · Cited by 22
Modulation of Vasoactivity and Platelet Aggregation by Selective 5-HT Receptor Antagonism in Humans
Moerland, M., Kemme, M. J. B., Dijkmans, A. C., Bergougnan, L., & Burggraaf, J. (2011) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e31822f6b8d · Cited by 21
Serotonin-2A receptor gene polymorphisms are associated with serotonin-induced platelet aggregation
Shimizu, M., Kanazawa, K., Matsuda, Y., Takai, E., Iwai, C., Miyamoto, Y., Hashimoto, M., Akita, H., & Yokoyama, M. (2003) · Thrombosis Research · doi:10.1016/j.thromres.2003.12.002 · Cited by 21
Multiple Roles of Tissue Plasminogen Activator in Schizophrenia Pathophysiology
Nardi, A. E., & Hoirisch-Clapauch, S. (2013) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0033-1357505 · Cited by 19
Dietrich‐Muszalska, A., Rabe‐Jabłońska, J., & Olas, B. (2009) · The World Journal of Biological Psychiatry · doi:10.1080/15622970903144020 · Cited by 18
Self-citationBakken, A. M., Staeffler, A., Jørgensen, H. A., & Holmsen, H. (2006) · Platelets · doi:10.1080/09537100600759196 · Cited by 18
Dietrich‐Muszalska, A., & Olas, B. (2009) · The World Journal of Biological Psychiatry · doi:10.1080/15622970902718790 · Cited by 17
Self-citationDietrich‐Muszalska, A., & Olas, B. (2010) · The World Journal of Biological Psychiatry · doi:10.3109/15622970902718790 · Cited by 17
Self-citationAntidepressant Treatment and Global Tests of Coagulation and Fibrinolysis
Lederbogen, F., Weber, B., Colla, M., Heuser, I., Deuschle, M., & Dempfle, C.-E. H. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n0210g · Cited by 14
Neuroleptic effects on platelet aggregation: a study in normal volunteers and schizophrenics
Dinan, T. G. (1987) · Psychological Medicine · doi:10.1017/s0033291700000672 · Cited by 14
Antipsychotic drugs and venous thromboembolism
Tromeur, C., & Couturaud, F. (2012) · Thrombosis Research · doi:10.1016/j.thromres.2012.08.267 · Cited by 13
Blood Platelet as a Peripheral Cell in Oxidative Stress in Psychiatric Disorders
Wachowicz, B. (2014) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-1-4939-0440-2_16 · Cited by 12
Self-citationThe Effect of Psychoactive Drugs on in vitro Platelet Function
Schedel, A., Thornton, S., Klüter, H., & Bugert, P. (2010) · Transfusion Medicine and Hemotherapy · doi:10.1159/000319841 · Cited by 11
The Blood Platelet: An Intriguing Cell
Ghumlas, A. K. A., & Gader, A. G. M. A. (2013) · Journal of Applied Hematology · Cited by 11
Possible Role of Platelet GluR1 Receptors in Comorbid Depression and Cardiovascular Disease
Chen, H. (2009) · Cardiovascular Psychiatry and Neurology · doi:10.1155/2009/424728 · Cited by 8
Oxidative Stress in Schizophrenia
Dietrich‐Muszalska, A. (2014) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-1-4939-0440-2_2 · Cited by 6
Self-citationThe Role of Nitric Oxide and Nitrosative Stress in Schizophrenia
Dietrich‐Muszalska, A., Bartosz, G., & Sadowska‐Bartosz, I. (2014) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-1-4939-0440-2_15 · Cited by 4
Self-citationReddy, R. D., Keshavan, M. S., & YAO, J. K. (2007) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2007.04.019 · Cited by 2
Research works printed but not linked: 9
- Al Ghumlas AK, 2013, J Applied Hematol, 4, 1
- De Clerck F., 1990, Clin Physiol Biochem, 8, 40
- 10.3109/15622970903144020 · doi:10.3109/15622970903144020
- Fisar Z, 2008, Neuro Endocrinol Lett, 29, 17
- Halaris A., 2009, Int Angiol, 28, 92
- Horstman LL, 2010, J Neuroinflammation, 3, 7
- 10.1371/journal · doi:10.1371/journal
- Semiz M, 2013, J Res Med Sci, 18, 560
- Shulman M, 2013, Minerva Med, 104, 175
Cited by
Mazza, M. G., Palladini, M., De Lorenzo, R., Magnaghi, C., Poletti, S., Furlan, R., Ciceri, F., Rovere-Querini, P., & Benedetti, F. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2021.02.021 · Cited by 513
“Platelet activation is mediated by serotonin, dopamine, glutamate, cytokines and P-selectin, all of them plays an important role in psychiatric disorders (Dietrich-Muszalska and Wachowicz, 2017).”
Neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in mood disorders: A meta-analysis
Mazza, M. G., Lucchi, S., Tringali, A. G. M., Rossetti, A., Botti, E. R., & Clerici, M. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.03.012 · Cited by 326
“The activation of platelets, mediated by various inflammatory factors including mainly cytokines, serotonin, glutamate, dopamine and P-selectin, plays an important role in psychiatric disorders (Dietrich-Muszalska and Wachowicz, 2017).”
BackgroundMazza, M. G., Lucchi, S., Rossetti, A., & Clerici, M. (2020) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2019.1583371 · Cited by 191
Inflammatory mediators in major depression and bipolar disorder
Poletti, S., Mazza, M. G., & Benedetti, F. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-02921-z · Cited by 163
“Platelet activation is mediated by serotonin, dopamine, glutamate, cytokines, and P-selectin, all of which play generally an important role in psychiatric disorders [38].”
BackgroundKayhan, F., Gündüz, Ş., Ersoy, S. A., Kandeğer, A., & Annagür, B. B. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2016.11.016 · Cited by 106
“The activation of platelet and hemostatic changes have important role on psychiatric disorders besides inflammatory process (Dietrich-Muszalska and Wachowicz, 2016).”
Metadata
- Authors
- Dietrich-Muszalska, A., & Wachowicz, B.
- Affiliations
- Department of Biological Psychiatry of the Chair of Experimental and Clinical Physiology, Medical University of Lodz, Lodz, Poland;
- University of Łódź (PL)
- Venue
- The World Journal of Biological Psychiatry
- Publisher
- Informa UK Limited
- Published
- 2016-04-26
- Volume
- 18
- Issue
- 8
- Pages
- 564-574
- ISSN
- 1562-2975 (ISSN-L)
- 1814-1412
- OpenAlex
- W2342847179
- Semantic Scholar
- e057aa50878134c060a2ddbaab9ef365a98dd736
- Cited by
- 78
- References
- 130
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 17 · 2023: 7 · 2022: 10 · 2021: 14 · 2020: 6 · 2019: 7 · 2018: 3 · 2017: 5 · 2016: 1
- FWCI
- 0.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The World Journal of Biological Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Keywords
- platelet activation, platelet function, hemostasis, schizophrenia, depression, antidepressants, antipsychotic drugs, venous thromboembolism, hemorrhage, cardiovascular risk, peripheral biomarkers, adverse drug reactions
- MeSH terms
- Antidepressive Agents, Mental Disorders, Blood Platelets, Hemostasis, Humans, Antipsychotic Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.